Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Acasti Pharma Inc. | VP Clinical Operations | Stock Options (Right to Buy) | 19.7K | May 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACST | Acasti Pharma Inc. | May 6, 2024 | 1 | $0 | 4/A | May 10, 2024 | VP Clinical Operations |
ACST | Acasti Pharma Inc. | May 6, 2024 | 1 | $0 | 4 | May 8, 2024 | VP Program Management |
ACST | Acasti Pharma Inc. | Jul 14, 2023 | 1 | $0 | 4 | Jul 18, 2023 | VP Clinical Operations |
ACST | Acasti Pharma Inc. | May 8, 2023 | 0 | $0 | 3 | May 18, 2023 | VP Clinical Operations |